Advancing drug delivery: New framework links lipid nanoparticle structure to immune response
A new framework bridges a gap in understanding RNA therapeutics by linking the structure of lipid nanoparticles to immune response.
NEWS Online - Health
Read More »
Rubi Pingree
21:24
The 10 Best Hoverboards of 2024, According to Editors
Swagtron and Segway top our testing list...
Alejandro Schildgen
21:24
Psyllium Husk Powder Is an “it” Supplement. But Should it Be?
There are benefits—and risks...
Nancie Menjivar
21:24
What Is ‘Cock Blocking,’ Again?
And should we even be saying it anymore...
Clora Mischke
18:21
Mutational Profile Can Help Guide Waldenström Treatment
NEW YORK — In the wake of details about the molecular pathophysiology of Waldenström macroglobulinemia (WM), an expert gave an
Jeanice Schildgen
18:21
Lymphoma Debate: CAR T Not a Clear Winner
NEW YORK — In a three-way debate on whether to prioritize chimeric antigen receptor (CAR) T-cell therapy, bispecific antibodies (BsAbs),
Buffy Kucera
18:21
More Evidence Ties Semaglutide to Reduced Alzheimer’s Risk
A new study provides real-world evidence to support the potential repurposing of glucagon-like peptide 1 receptor agonists (GLP-1 RAs), used
Sharie Pecora
16:19
ACIP Votes to ‘Harmonize’ Dosing and Interval for Meningococcal B Vaccines
MedPage Today) -- The CDC's Advisory Committee on Immunization Practices (ACIP) on Thursday unanimously endorsed revising the dosing and interval
Joan Latson
16:19
GLP-1 Drugs Tied to Reduced Risk of Uterine Fibroids
MedPage Today) -- DENVER -- In women with type 2 diabetes, use of GLP-1 receptor agonists was associated with a
Rebecka Fleishman
16:19
Ozempic Linked With Lower Risk of Alzheimer’s Diagnosis
MedPage Today) -- Semaglutide (Ozempic) was tied to a reduced risk of Alzheimer's disease diagnoses in people with type 2
